Biykem Bozkurt

Q: What Schools Are Affiliated With Biykem Bozkurt

Biykem Bozkurt is affiliated with the following schools: Baylor College of Medicine, Baylor University, Massachusetts General Hospital

Biykem Bozkurt's AcademicInfluence.com Rankings

Biykem Bozkurt

Philosophy

#6471

World Rank

#9512

Historical Rank

Logic

#3629

World Rank

#4820

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Biykem Bozkurt's Degrees

Doctorate Medicine Hacettepe University

Why Is Biykem Bozkurt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Biykem Bozkurt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (9561)
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (6648)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (5272)
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (3504)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (2433)
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (2118)
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (1905)
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (1904)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1845)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1330)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013) (1053)
Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. (1998) (837)
Third universal definition of myocardial infarction. (2012) (751)
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (712)
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (2014) (666)
Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. (2012) (598)
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (596)
Reprint: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. (2013) (583)
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (583)
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (579)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (560)
Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction (2008) (502)
Myocarditis With COVID-19 mRNA Vaccines (2021) (477)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (467)
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. (2016) (445)
Basic mechanisms in heart failure: the cytokine hypothesis. (1996) (441)
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome (2020) (422)
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions (2020) (398)
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (396)
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure (2021) (395)
Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure (2001) (381)
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. (1999) (375)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association (2017) (367)
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 (2020) (353)
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association (2018) (349)
Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. (2013) (285)
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2013) (277)
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. (2012) (265)
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. (2021) (263)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (250)
Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. (2003) (235)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (235)
Venoarterial ECMO for Adults: JACC Scientific Expert Panel. (2019) (229)
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. (2016) (229)
Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. (2013) (211)
Intravenous immune globulin in the therapy of peripartum cardiomyopathy. (1999) (210)
Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. (2012) (208)
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary (2015) (196)
Biomarkers of inflammation in heart failure (2010) (187)
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. (2009) (184)
Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). (2011) (182)
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee. (2019) (173)
Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. (2002) (172)
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (166)
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. (2021) (157)
Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure (2010) (155)
2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary (2017) (137)
Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. (2015) (127)
2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play (2022) (123)
The role of cytokines in the failing human heart. (1998) (118)
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (115)
Acute Bacterial Pneumonia is Associated With the Occurrence of Acute Coronary Syndromes (2008) (108)
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. (2002) (105)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (103)
Delayed recovery in peripartum cardiomyopathy: an indication for long‐term follow‐up and sustained therapy (2012) (102)
Universal Definition and Classification of Heart Failure. (2021) (98)
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization (2020) (96)
An overview of tumor necrosis factor α and the failing human heart (1999) (95)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (90)
Obesity as a prognostic factor in chronic symptomatic heart failure. (2005) (89)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2015) (87)
Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. (2010) (86)
Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. (2014) (82)
Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. (2006) (78)
Writing Committee Members 3 (2014) (78)
Safety and Efficacy of a Soluble P 75 Tumor Necrosis Factor Receptor ( Enbrel , Etanercept ) in Patients With Advanced Heart Failure (1999) (75)
Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. (2016) (71)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) (71)
Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (71)
Lifestyle Modifications for Preventing and Treating Heart Failure. (2018) (70)
Cytokines in heart failure: pathogenetic mechanisms and potential treatment. (1999) (69)
Cardiac remodeling as a consequence and cause of progressive heart failure (1998) (68)
Does the level of experience of residents affect outcomes of coronary artery bypass surgery? (2009) (66)
Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. (2014) (64)
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standar (2012) (63)
New therapeutics for chronic heart failure. (2002) (62)
Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. (2011) (61)
Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy (2021) (59)
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. (2014) (58)
Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations (2020) (58)
Shortness of Breath (2003) (56)
Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. (2015) (56)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (53)
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). (2020) (52)
Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. (2009) (51)
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (51)
Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. (2013) (51)
Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel. (2021) (50)
Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives. (2020) (48)
Diagnosis and management of acute heart failure (2015) (47)
The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. (2008) (46)
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. (2021) (45)
Use of biomarkers in the management of heart failure: are we there yet? (2003) (43)
Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. (2012) (43)
An overview of tumor necrosis factor alpha and the failing human heart. (1999) (42)
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. (2013) (41)
BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. (2017) (37)
Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. (2012) (36)
The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. (2007) (36)
Cardiac ScoreCard: A diagnostic multivariate index assay system for predicting a spectrum of cardiovascular disease (2016) (35)
Cardiovascular toxicity with highly active antiretroviral therapy (2007) (35)
High-Sensitivity Troponin T and Cardiovascular Events in Systolic Blood Pressure Categories: Atherosclerosis Risk in Communities Study (2015) (35)
Heart Failure in Women. (2017) (34)
What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines (2018) (33)
Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. (2002) (33)
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) (2013) (33)
Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. (2008) (32)
Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction? (2013) (31)
Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study. (2012) (30)
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure) (2021) (29)
Barriers to non-HDL cholesterol goal attainment by providers. (2011) (29)
Endpoints in Heart Failure Drug Development: History and Future. (2020) (29)
Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. (2013) (27)
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary (2022) (27)
Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions (2014) (26)
Activation of cytokines as a mechanism of disease progression in heart failure (2000) (26)
Effect of the Soluble TNF‐Antagonist Etanercept on Tumor Necrosis Factor Bioactivity and Stability (2008) (25)
New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. (2012) (24)
Age-Stratified Sex Disparities in Care and Outcomes in Patients with ST-elevation Myocardial Infarction. (2020) (24)
Sexual Activity and Cardiovascular Disease : A Scientific Statement From the (2012) (24)
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry (2018) (23)
Chagas cardiomyopathy is associated with higher incidence of stroke: a meta-analysis of observational studies. (2014) (23)
ACC/AHA 2013 Methodology for Developing Clinical Data Standards: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (2014) (23)
Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. (2017) (23)
The Role of Anti-Cytokine Therapy in the Failing Heart (2001) (22)
Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure. (2019) (21)
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. (2009) (21)
Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. (2011) (21)
Worsening renal function is not associated with response to treatment in acute heart failure. (2013) (20)
The association between Staphylococcus aureus bacteremia and acute myocardial infarction (2009) (20)
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (20)
Progressive Left Ventricular Dysfunction and Remodeling in Rats Promote α Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-Print (1998) (19)
Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study (2017) (18)
Sex Differences in Heart Failure. (2021) (18)
Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. (2011) (18)
Cardiovascular risk and complications associated with COVID-19. (2020) (17)
Usefulness of the Sum of Pulmonary Capillary Wedge Pressure and Right Atrial Pressure as a Congestion Index that Prognosticates Heart Failure Survival (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). (2016) (17)
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System (2020) (17)
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. (2014) (16)
Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. (2014) (16)
The metabolic syndrome and mortality in an ethnically diverse heart failure population. (2008) (15)
Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy (2019) (15)
Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. (2017) (15)
Veterans Affairs Quality Enhancement Research Initiative in chronic heart failure. (2000) (15)
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. (2021) (14)
Acoustic Detection of Coronary Occlusions before and after Stent Placement Using an Electronic Stethoscope (2016) (14)
Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). (2022) (14)
American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations (2018) (14)
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry (2015) (14)
HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy. (2021) (14)
Peripartum cardiomyopathy: a contemporary review. (2013) (13)
Response to Ryan and Parwani: heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs? (2012) (13)
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases (2021) (13)
Impact of the SARS-CoV-2 pandemic on health-care workers (2020) (13)
CHAGAS' CARDIOMYOPATHY IS ASSOCIATED WITH A HIGHER INCIDENCE OF STROKE: A META ANALYSIS OF OBSERVATIONAL STUDIES (2014) (12)
Central venous pressure and pulmonary capillary wedge pressure: fresh clinical perspectives from a new model of discordant and concordant heart failure. (2011) (12)
Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy (2018) (12)
2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure. (2021) (12)
Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study. (2018) (12)
Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap (2022) (11)
Early experience of a transcatheter aortic valve program at a Veterans Affairs facility. (2013) (11)
Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility. (2012) (11)
Abstract 13740: Increasing Prevalence and Hospital Charges in Pediatric Heart Failure Related Hospitalizations in the United States: A Population-Based Study (2010) (11)
Medical and surgical therapy for cardiac remodeling. (1999) (10)
2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) and the American Society of Ec (2019) (10)
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy (2021) (10)
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies (2021) (9)
Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States. (2021) (8)
Task Force on Practice Guidelines Report of the American College of Cardiology Foundation/American Heart Association 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A (2013) (8)
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (2022) (8)
Where do we currently stand with advice on hormone replacement therapy for women? (2010) (7)
Re‐examining the widespread policy of stopping sodium‐glucose cotransporter‐2 inhibitors during acute illness: A perspective based on the updated evidence (2022) (7)
Target Dose Versus Maximum Tolerated Dose in Heart Failure: Time to Calibrate and Define Actionable Goals. (2019) (6)
Transcatheter aortic valve replacement as a treatment for late apicoaortic conduit obstruction in a patient with severe aortic stenosis. (2013) (6)
Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey. (2018) (6)
Tumor necrosis factor-α and tumor necrosis factor receptors in human heart failure (1996) (6)
CONTINUOUS WEARABLE MONITORING ANALYTICS PREDICT HEART FAILURE DECOMPENSATION: THE LINK-HF MULTI-CENTER STUDY (2018) (6)
Substance and Substrate (2020) (6)
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19 (2022) (5)
Sexual Activity and Cardiovascular Disease : A Scientific Statement From the American (2012) (5)
The treatment of heart failure in the 21st century: is the glass half empty or half full? (2013) (5)
ACCF/AHA Practice Guideline (2013) (4)
Abstract 2003: Prevalence of Heart Failure Related Hospitalizations and Risk Factors for Mortality in Pediatric Patients: An Analysis of a Nationwide Sampling of Hospital Discharges (2009) (4)
Does the use of bilateral internal mammary artery grafts impact survival of veterans undergoing coronary artery bypass surgery? (2008) (4)
Treatment of patients with heart failure and preserved ejection fraction (2008) (4)
Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T (2015) (4)
Randomized Trial of Aldosterone AntagonisM in Diastolic Heart Failure (RAAM-DHF) (2010) (4)
Enkephalins and the Opioid System of the Heart. (2019) (3)
Fourth Annual Go Red for Women Issue. (2020) (3)
Role of immune globulin in the treatment of postpartum cardiomyopathy (1998) (3)
ACC/AHA Clinical Practice Guideline (2014) (3)
The 2017 AHA/ACC Performance and Quality Measures for Patients With Acute Myocardial Infarction. (2018) (3)
Cost of Heart Failure Admissions in Children in the United States (2010) (3)
Proinflammatory TH17 cytokine activation, disease severity and outcomes in peripartum cardiomyopathy. (2021) (3)
Experimental options in the treatment of heart failure: the role of cytokine antagonism. (2001) (3)
How to Initiate and Uptitrate GDMT in Heart Failure: Practical Stepwise Approach to Optimization of GDMT. (2022) (3)
The Assessment of Stent Effectiveness Using a Wearable Beamforming MEMS Microphone Array System (2016) (3)
Endpoints in Heart Failure Drug Development (2022) (2)
Chapter 24 – Heart Failure as a Consequence of Dilated Cardiomyopathy (2011) (2)
Cardiac rehabilitation in heart failure: Indications for exercise training based on heart failure phenotype. (2021) (2)
Improved propensity matching for heart failure using neural gas and self-organizing maps (2009) (2)
Sixth Annual Go Red for Women Issue. (2022) (2)
An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps (2022) (2)
Guiding left ventricular lead positioning and refining ability to predict response and nonresponse to cardiac resynchronization therapy using dP/dt max: killing 3 birds with 1 high-fidelity wire? (2011) (2)
Ventricular Assist Devices as Alternatives to Biologic Replacement of the Heart (1997) (2)
WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT? (2019) (2)
Update in recent clinical trials in heart failure. (2019) (2)
Mechanisms of idiopathic dilated cardiomyopathies (2006) (2)
Cardiology patient page. Shortness of breath. (2003) (2)
Clinical Investigations Prevalence, Morbidity, and Mortality of Heart FailureeRelated Hospitalizations in Children in the United States: A Population-Based Study (2012) (2)
Public perception of heart failure on twitter: A sentiment analysis. (2021) (2)
Neprilysin Inhibitors in Heart Failure (2022) (2)
Successful Decongestion as a Clinical Target, Performance Indicator, and as a Study Endpoint in Hospitalized Heart Failure Patients. (2023) (2)
Factor Xa Inhibition, A New Strategy for Prevention of Adverse Cardiac Remodeling in Early Stages?∗ (2020) (1)
JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (1)
Unsupervised cluster analysis and mortality risk in the Digitalis Investigation Group (DIG) trial of heart failure (2009) (1)
Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: Atherosclerosis Risk in Communities (ARIC) Study. (2023) (1)
Ins and Outs: Perspectives of Inpatient Prescribing for Sacubitril/Valsartan (2020) (1)
High‐Sensitivity Cardiac Troponin: From Patient Phenotypes to Clinical Events in Patients With Heart Failure With Preserved Ejection Fraction (2018) (1)
Telehealth in Heart Failure. (2022) (1)
Third Annual Go Red for Women Issue. (2019) (1)
Abstract 18911: Relaxin-2 Levels and Early Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study (2015) (1)
Correction to Circulating Collagen Biomarkers as Indicators of Disease Severity in Pulmonary Arterial Hypertension [J Am Coll Cardiol HF, (2014), 2, 412-421] (2015) (1)
Heart Failure as a Consequence of Dilated Cardiomyopathy (2020) (1)
Aldosterone Antagonism in the Pharmacological Management of Chronic Heart Failure (2007) (1)
Cardiology/American Heart Association Task Force on Practice Guidelines and 2011 ACCF/AHA/HRS Recommendations): A Report of the American College of Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC (2014) (1)
The Need to Stop Inappropriate Coding for Acute Kidney Injury in Heart Failure. (2022) (1)
The Emergence of the HF and Critical Care Medicine Specialist: An Unmet Need That Needs a Rapid Solution. (2021) (1)
Abstract 19671: Percutaneous Coronary Interventions with Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis are Associated with Reduced Stroke and Increased Repeat Revascularization Risk Compared with Coronary Artery Bypass Graft Surgery: Results from a Contemporary Aggregate Dat (2010) (1)
IN PATIENTS WITH SEVERE ADVANCED HEART FAILURE THE USE OF ADAPTIVE SERVO-VENTILATION (ASV) DECREASES HEART FAILURE EVENTS: A POOLED META ANALYSIS OF 629 PATIENTS WITH CENTRAL SLEEP APNEA AND CHENEY STOKES RESPIRATION (CSA-CSR) (2015) (1)
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity? (2022) (1)
Targets for Success in Treatment of Patients Hospitalized for Heart Failure. (2022) (1)
Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. (2023) (1)
TROPONIN T IDENTIFIES INDIVIDUALS AT HIGHER RISK FOR HEART FAILURE AMONG ALL BLOOD PRESSURE CATEGORIES IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2014) (1)
Impact of a Resident-Centered Interprofessional Quality Improvement Intervention on Acute Care Length of Stay. (2019) (1)
What to and Not to Monitor for Uptitration of GDMT in Patients With Heart Failure: The Case for Patient Self-Uptitration of GDMT. (2022) (1)
Abstract 15347: Provider Type and Quality of Outpatient Cardiovascular Disease Care, Implications for the Affordable Care Act: Insights from the NCDR®PINNACLE Registry (2014) (1)
The clinical experience with anti-cytokine therapy in heart failure (2003) (1)
Guiding Left Ventricular Lead Positioning and Reﬁning Ability to Predict Response and Nonresponse to Cardiac Resynchronization Therapy Using dP/dt max (2011) (1)
VASCULAR FUNCTION IS ABNORMAL IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA (2005) (1)
Thiazolidinediones Are Not Associated with Increased Risk of Heart Failure Hospitalizations in Ambulatory Patients with Diabetes Mellitus and Heart Failure (2006) (1)
From the American Heart Association -Thalassemia Major: A Consensus Statement β Cardiovascular Function and Treatment in (2014) (0)
Chapter 27 – Myocarditis (2010) (0)
Abstract 11035: Worsening Renal Function in Hospitalized Heart Failure Patients with Preserved vs. Reduced Ejection Fraction (2010) (0)
IMPACT OF COMORBIDITIES ON HEART FAILURE HOSPITALIZATIONS AND ALL CAUSE HOSPITALIZATIONS IN AMBULATORY PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (2013) (0)
Outcomes of Hospitalizations With Septic Shock Complicated by Types 1 and 2 Myocardial Infarction. (2022) (0)
Hemoglobin Drop during Hospitalization Predicts Poor Survival in Anemic Patients with Acute Decompensated Heart Failure (2009) (0)
Fifth Annual Go Red for Women Issue. (2020) (0)
ASPIRIN DOSING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH TICAGRELOR: INSIGHT FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY (NCDR) (2016) (0)
1012-122 Chronic treatment with carvedilol improves left ventricular pump performance by increasing intrinsic myocardial contractility in patients with heart failure (2004) (0)
Shedding Light on Mechanisms of Myocarditis With COVID-19 mRNA Vaccines (2023) (0)
Abbreviated Title ( Length 26 characters ) : BNP in obesity and HFpEF 2 (2013) (0)
Continuous Wearable Monitoring Analytics To Improve Outcomes In Heart Failure: Vanguard Phase Results And Study Design Of The Randomized Phase Of Link-HF2 Multicenter Study (2023) (0)
JAMA Cardiology List of Peer Reviewers. (2017) (0)
Inflammatory Biomarkers in HF (2012) (0)
Central Venous Pressure and Pulmonary Capillary Wedge Pressure Fresh Clinical Perspectives from a New Model of Discordant and Concordant Heart Failure New Heart-Failure (2011) (0)
Abstract 13209: High Sensitivity Troponin T Levels are Reduced by Beta Blocker Treatment in Heart Failure Patients: First Prospective Clinical Study of Prevention of Subclinical Injury in Heart Failure (2013) (0)
Abnormalities in cardiac and inflammatory biomarkers in ambulatory subjects after COVID-19 infection (2022) (0)
Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association. (2022) (0)
Abstract 16587: Racial Differences in Circulating Natural Killer Cells in Peripartum Cardiomyopathy: Results of the NHLBI Sponsored IPAC Investigation (2013) (0)
PREDICTING IN-HOSPITAL CLINICAL TRAJECTORIES USING MACHINE LEARNING IN PATIENTS ADMITTED WITH ACUTE DECOMPENSATED HEART FAILURE (2023) (0)
President's Message (2020) (0)
Abstract 18999: The Evolution of Heart Failure Trials: 1986-Present (2017) (0)
TROPONIN I IS CHRONICALLY AND PERSISTENTLY ELEVATED IN HOSPITALIZED HEART FAILURE PATIENTS AND IS ASSOCIATED WITH INCREASED MORTALITY OVER FIVE YEARS (2010) (0)
RACIAL VARIATIONS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION IN A NATIONAL AMBULATORY HEART FAILURE COHORT (2011) (0)
Explant Myocarditis: Evidence for the Role of Inflammation in Decompensation of Advanced Heart Failure Patients (1998) (0)
Outcomes and Resource Utilization in Patients Hospitalized with Gastrointestinal Bleeding Complicated by Types 1 and 2 Myocardial Infarction. (2022) (0)
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines (2022) (0)
ASSOCIATION OF NT-PROBNP, PULSE PRESSURE WITH HEART FAILURE AND CARDIOVASCULAR EVENTS: ATHEROSCLEROSIS RISK IN COMMUNNITIES (ARIC) STUDY (2020) (0)
Abstract 19771: Persistent Thrombocytopenia after Myocardial Infarction is Associated with Increased Short- and Long-Term Mortality (2014) (0)
Barriers to Non-HDL-Cholesterol Goal Attainment: Exploring the Gaps in Knowledge, Attitude, and Practices of Providers* (2011) (0)
Abstract 1074: A Propensity Matched Analysis of Prognostic Implications of Systolic Blood Pressure in Patients With Stable Heart Failure (2009) (0)
IN PATIENTS WITH SEVERE ADVANCED HEART FAILURE, NON RESPONSE TO DECREASE LV FILLING PRESSURE IS NOT ASSOCIATED WITH WORSE SURVIVAL AND OUTCOMES: INSIGHTS FROM THE ESCAPE (EVALUATION STUDY OF CONGESTIVE HEART FAILURE AND PULMONARY ARTERY CATHETERIZATION EFFECTIVENESS) TRIAL (2015) (0)
Lower Heart Rate Associated With Improved Outcomes in Heart Failure With Preserved Ejection Fraction (2012) (0)
Heart Failure, Introduction (2015) (0)
No Increase in Mortality Seen with β-blocker Treatment in Heart Failure Patients with Cocaine Use (2015) (0)
Biomarkers of Inflammation (2006) (0)
Loss after Initial Gain in LVEF With ß-Blocker Therapy in Heart Failure Patients (2010) (0)
UTILIZATION RATES OF SGLT2 INHIBITORS AND THEIR FACILITY-LEVEL VARIATION AMONG PATIENTS WITH TYPE 2 DIABETES (T2DM), HEART FAILURE (HF) AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD): INSIGHTS FROM THE DEPARTMENT OF VETERANS AFFAIRS (VA) (2023) (0)
Hyperacute T-waves: Wolff-Parkinson-White pattern or acute coronary syndrome? (2013) (0)
Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease (2019) (0)
Abstract 20205: Patients with Severe Chronic Kidney Disease have Survival Benefit from Initial Invasive Therapy and Early Revascularization after Acute Coronary Syndrome (2010) (0)
A MULTICENTER STUDY OF THE ETIOLOGY AND OUTCOME OF CARDIAC TAMPONADE IN THE CONTEMPORARY ERA (2016) (0)
ASSOCIATION BETWEEN 6-YEAR CHANGE IN NT-PROBNP WITH HEART FAILURE AND DEATH: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2022) (0)
Ca2+/Calmodulin Dependent Protein Kinase II Phosphorylation of RyR2 Alters the Force-Frequency Relationship in Mice (2011) (0)
On the Shoulders of Witnesses: A Conversation With Biykem Bozkurt, MD, PhD. (2022) (0)
Design of the remedē System Therapy (rēST) study: A prospective non-randomized post-market study collecting clinical data on safety and effectiveness of the remedē system for the treatment of central sleep apnea. (2022) (0)
JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
Treatment of Advanced (Stage D) Heart Failure in the New Era. (2023) (0)
JACC Journals’ Pathway Forward With AI Tools (2023) (0)
Chapter 27 – Heart Failure: Long-Term Management (2018) (0)
Association of NT-proBNP, Blood Pressure, and Cardiovascular Events: Atherosclerosis Risk in Communities Study (2021) (0)
Chapter-10 Systolic Heart Failure and Dilated Cardiomyopathies (2015) (0)
Abstract 16960: Prognostic Significance of Hypoalbuminemia Among Ambulatory Heart Failure Patients With Reduced and Preserved Ejection Fraction (2013) (0)
Do We Currently Have an Ideal Biomarker for Guiding the Management of Heart Failure Patients ? (2003) (0)
PRE-MORBID BODY MASS INDEX, HIGH SENSITIVITY TROPONIN-T AND MORTALITY AFTER INCIDENT HEART FAILURE HOSPITALIZATION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY (ARIC) (2015) (0)
Chapter 28 – Dilated Cardiomyopathy (2010) (0)
Effect of Digoxin on Clinical Outcomes in Patients on Contemporary Heart Failure Therapy (2008) (0)
Chapter 22 – Dilated Cardiomyopathy (2018) (0)
Premorbid Body-Mass Index and Mortality after Incident Heart Failure: The Atherosclerosis Risk in Communities Study (2014) (0)
JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction. (2023) (0)
Abstract 17833: Efficacy of Hydralazine and Nitrate Therapy in ACE Intolerant Heart Failure Patients (2012) (0)
Cardiac Resynchronization Therapy in Reversing “Decapitated Hypertension” – A Meta-Analysis (2009) (0)
Abstract 18417: Complex Interaction of the Prognostic Value of Systolic Blood Pressure with the Degree and Type of Heart Failure (2010) (0)
JACC: Heart Failure Christopher O'Connor Award for Outstanding Scholarship. (2023) (0)
Abstract 16254: Heart Rate as a Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction (2015) (0)
Chapter 23 – Heart Failure Evaluation and Long-Term Management (2014) (0)
Women leaders: transforming the culture in cardiology (2022) (0)
THE NONDIFFERENTIAL EFFECT OF CHRONIC β-BLOCKER TREATMENT ON LEFT VENTRICULAR FUNCTION AND MYOCARDIAL GLUCOSE UPTAKE IN HEART FAILURE PATIENTS (2010) (0)
JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
Abstract 16232: Prognostic Significance of Hyponatremia among Ambulatory Heart Failure Patients with Preserved Ejection Fraction (2012) (0)
Update: shortness of breath. (2014) (0)
Chapter 25 – Digoxin and Other Positive Inotropic Agents (2010) (0)
Chapter 26 – Dilated Cardiomyopathy (2014) (0)
Proposed New Conceptualization for Definition of Decompensated HF: Taking the Acute Out of Decompensation. (2023) (0)
Abstract 12042: The "Obesity Paradox" in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction (2013) (0)
Supplementary material : Gender Disparities in Evidence-Based Statin Therapy in Patients With Cardiovascular Disease (2014) (0)
Abstract 20656: Publication Rates of Abstracts Presented at Major Cardiovascular Subspecialty Conferences (2016) (0)
5 6 Developed in Collaboration With the American Academy of Family Physicians, American College 7 of Chest Physicians, Heart Rhythm Society and International Society for Heart and Lung (2013) (0)
JACC Journals’ Pathway Forward With AI Tools (2023) (0)
Abstract 18283: Prognostic Impact of Comorbidities on Mortality in Patients with Heart failure and Preserved Ejection Fraction vs Heart Failure with Reduced Ejection Fraction (2010) (0)
How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines? (2022) (0)
It Is Time to Screen for Heart Failure: Why and How? (2022) (0)
SAFETY AND EFFECTIVENESS OF BALLOON AORTIC VALVULOPLASTY FOR SEVERE AORTIC STENOSIS IN THE CONTEMPORARY ERA (2014) (0)
Differences between Academic and Non-Academic Institutions in Heart Failure Clinical Trials in North America: Insights from the HFSA Research Network Survey (2019) (0)
Optimizing outcomes in heart failure: 2022 and beyond. (2023) (0)
Dapagliflozin utilization following hospitalization for heart failure: real-world insights from EVOLUTION HF, a multinational, observational study (2022) (0)
Futility of Digoxin in a Sub-Population of Heart Failure Patients – A Cluster Analysis of DIG Data (2009) (0)
President's Message (2008) (0)
MORTALITY, CLINICAL EVENTS AND HEALTHCARE COSTS AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE: INSIGHTS FROM EVOLUTION HF (2023) (0)
PROGNOSTIC SIGNIFICANCE OF CHANGE IN HEMOGLOBIN DURING ACUTE HEART FAILURE ADMISSION (2012) (0)
Lack of Association of Changes in BNP with Cardiorenal Syndrome during Treatment of Acute Decompensated Heart Failure (2011) (0)
JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
Abstract 3019: Lack of Benefit and Potential Harm With Digoxin in Hypertensive Heart Failure Patients (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Biykem Bozkurt?

Biykem Bozkurt is affiliated with the following schools: